Development and Validation of DIANA (Diabetes Novel Subgroup Assessment tool): A web-based precision medicine tool to determine type 2 diabetes endotype membership and predict individuals at risk of microvascular disease.
Journal:
PLOS digital health
Published Date:
Aug 5, 2025
Abstract
BACKGROUND: Previous research has identified four distinct endotypes of type 2 diabetes in Asian Indians, which include Severe Insulin Deficient Diabetes (SIDD), Combined Insulin Resistant and Deficient Diabetes (CIRDD), Insulin Resistance and Obese Diabetes (IROD), and Mild Age-related Diabetes (MARD). DIANA (Diabetes Novel Subgroup Assessment) is an online precision medicine tool that can predict endotype membership of type 2 diabetes and individual risk for retinopathy and nephropathy.
Authors
Keywords
No keywords available for this article.